Literature DB >> 15299191

Enzyme activities controlling adenosine levels in normal and neoplastic tissues.

D Vannoni1, A Bernini, F Carlucci, S Civitelli, M C Di Pietro, R Leoncini, F Rosi, A Tabucchi, G Tanzini, E Marinello.   

Abstract

Adenosine is known to be associated with effects such as inhibition of immune response, coronary vasodilation, stimulation of angiogenesis, and inhibition of inflammatory reactions. Some authors suggest that adenosine may also have similar functions in tumor tissues. Tissue levels of adenosine are under close regulation by different enzymes acting at different levels. Adenosine is produced from AMP by the action of 5'-nucleotidase (5'-NT) and is converted back into AMP by adenosine kinase (AK) or into inosine by adenosine deaminase (ADA). Inosine is converted into purine catabolites by purine nucleoside phosphorylase (PNP), whereas AMP is converted into ADP and ATP by adenylate kinase (MK). The aim of this study was to analyze the activities of the above enzymes in fragments of neoplastic and apparently normal mucosa, obtained less than 5 cm and at least 10 cm from tumors, in 40 patients with colorectal cancer. The results showed much higher activities of ADA, AK, 5'-NT, and PNP in tumor tissue than in neighboring mucosa (p > 0.01 for ADA, AK, and PNP; p > 0.05 for 5'-NT), suggesting that the activities of purine metabolizing enzymes increase to cope with accelerated purine metabolism in cancerous tissue. The simultaneous increase in ADA and 5'-NT activities might be a physiological attempt by cancer cells to provide more substrate to accelerate salvage pathway activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15299191     DOI: 10.1385/MO:21:2:187

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  32 in total

1.  Purine metabolism in two human melanoma cell lines: relation to proliferation and differentiation.

Authors:  S Wei; M Reillaudou; F Apiou; H Peyre; F Pétridis; C Luccioni
Journal:  Melanoma Res       Date:  1999-08       Impact factor: 3.599

2.  Release of the glycosylphosphatidylinositol-anchored enzyme ecto-5'-nucleotidase by phospholipase C: catalytic activation and modulation by the lipid bilayer.

Authors:  M T Lehto; F J Sharom
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

Review 3.  Adenosine kinase inhibitors.

Authors:  E A Kowaluk; S S Bhagwat; M F Jarvis
Journal:  Curr Pharm Des       Date:  1998-10       Impact factor: 3.116

4.  Purine nucleoside phosphorylase: a new marker for free oxygen radical injury to the endothelial cell.

Authors:  P N Rao; T R Walsh; L Makowka; R S Rubin; T Weber; J T Snyder; T E Starzl
Journal:  Hepatology       Date:  1990-02       Impact factor: 17.425

5.  Purine metabolizing enzymes in lymphocytes from patients with solid tumors.

Authors:  J Mejer; S Hørbov; P Nygaard
Journal:  Acta Med Scand       Date:  1984

6.  Purine enzymology of human colon carcinomas.

Authors:  Y Natsumeda; M S Lui; J Emrani; M A Faderan; M A Reardon; J N Eble; J L Glover; G Weber
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

7.  Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts.

Authors:  P Meghji; K M Middleton; A C Newby
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

8.  Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.

Authors:  O Sanfilippo; M Camici; M G Tozzi; M Turriani; A Faranda; P L Ipata; R Silvestrini
Journal:  Cancer Biochem Biophys       Date:  1994-04

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Purification and properties of adenosine kinase from rat brain.

Authors:  Y Yamada; H Goto; N Ogasawara
Journal:  Biochim Biophys Acta       Date:  1980-12-04
View more
  13 in total

1.  Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon.

Authors:  Tova Rainis; Irit Maor; Amos Lanir; Sergay Shnizer; Alexandra Lavy
Journal:  Dig Dis Sci       Date:  2006-12-29       Impact factor: 3.199

2.  CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.

Authors:  Dachuan Jin; Jie Fan; Long Wang; Linda F Thompson; Aijie Liu; Benjamin J Daniel; Tahiro Shin; Tyler J Curiel; Bin Zhang
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.

Authors:  Lina Yang; Jingfang Wang; Jianfang Li; Hainan Zhang; Shujuan Guo; Min Yan; Zhenggang Zhu; Bin Lan; Youcheng Ding; Ming Xu; Wei Li; Xiaonian Gu; Chong Qi; Heng Zhu; Zhifeng Shao; Bingya Liu; Sheng-Ce Tao
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

Review 4.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

5.  Mammalian mismatches in nucleotide metabolism: implications for xenotransplantation.

Authors:  Zain Khalpey; Ada H Y Yuen; Marialuisa Lavitrano; Christopher G A McGregor; Kameljit K Kalsi; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Mol Cell Biochem       Date:  2007-07-27       Impact factor: 3.396

6.  Development of Adenosine Deaminase-Specific IgY Antibodies: Diagnostic and Inhibitory Application.

Authors:  Agnieszka Łupicka-Słowik; Mateusz Psurski; Renata Grzywa; Kamila Bobrek; Patrycja Smok; Maciej Walczak; Andrzej Gaweł; Tadeusz Stefaniak; Józef Oleksyszyn; Marcin Sieńczyk
Journal:  Appl Biochem Biotechnol       Date:  2017-10-17       Impact factor: 2.926

7.  Physiological Role of Glutamate Dehydrogenase in Cancer Cells.

Authors:  Rafael Moreno-Sánchez; Álvaro Marín-Hernández; Juan C Gallardo-Pérez; Silvia C Pacheco-Velázquez; Diana X Robledo-Cadena; Joaquín Alberto Padilla-Flores; Emma Saavedra; Sara Rodríguez-Enríquez
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

8.  Dysregulation of adenosine kinase isoforms in breast cancer.

Authors:  Bahar Shamloo; Nandita Kumar; Randall H Owen; Jesica Reemmer; John Ost; R Serene Perkins; Hai-Ying Shen
Journal:  Oncotarget       Date:  2019-12-31

9.  Alterations in adenylate kinase activity in human PBMCs after in vitro exposure to electromagnetic field: comparison between extremely low frequency electromagnetic field (ELF) and therapeutic application of a musically modulated electromagnetic field (TAMMEF).

Authors:  Antonietta Albanese; Emilio Battisti; Daniela Vannoni; Emilia Aceto; Gianmichele Galassi; Stefania Giglioni; Valentina Tommassini; Nicola Giordano
Journal:  J Biomed Biotechnol       Date:  2009-09-16

10.  Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms.

Authors:  Barbara Kutryb-Zajac; Patrycja Koszalka; Paulina Mierzejewska; Alicja Bulinska; Magdalena A Zabielska; Karolina Brodzik; Aleksandra Skrzypkowska; Lukasz Zelazek; Iwona Pelikant-Malecka; Ewa M Slominska; Ryszard T Smolenski
Journal:  J Cell Mol Med       Date:  2018-10-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.